1 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Phase 1/2 Study of SY-12321 in Patients With ALK-positive Advanced MalignanciesALK Positive Advanced MalignanciesRecruitingPhase 1 / Phase 22026-09-09NCT07810933